Sbi Securities Co., Ltd. Dyne Therapeutics, Inc. Call Options Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
212Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$165 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$160 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$155 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$125 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $878M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...